n(g),n(g')-dimethyl-l-arginine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 3 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute lymphoblastic leukemia (ALL) and its treatment are associated with endothelial dysfunction (ED) and increased cardiovascular risk in adulthood." | 1.48 | Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications. ( Huml, M; Jehlička, P; Kreslová, M; Masopustová, A; Sýkora, J; Trefil, L; Votava, T, 2018) |
| "Childhood acute lymphoblastic leukemia (ALL) survivors are at higher cardiovascular risk than the general population, which may result from anthracycline-related endothelial dysfunction (ED)." | 1.43 | Elevated plasma ADMA contributes to development of endothelial dysfunction in children with acute lymphoblastic leukemia. ( Chybicka, A; Doroszko, A; Jakubowski, M; Mazur, G; Niedzielska, E; Porwolik, J; Szahidewicz-Krupska, E; Szuba, A; Turek-Jakubowska, A, 2016) |
| "ADMA is elevated in adult childhood ALL survivors, which can reflect late detrimental chemotherapy effects, partially related to minor lipid profile changes." | 1.38 | Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report. ( Balwierz, W; Ćwiklińska, M; Grodzicki, TK; Gryglewska, B; Kwater, A; Strach, M; Sulicka, J; Surdacki, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masopustová, A | 1 |
| Jehlička, P | 1 |
| Huml, M | 1 |
| Votava, T | 1 |
| Trefil, L | 1 |
| Kreslová, M | 1 |
| Sýkora, J | 1 |
| Doroszko, A | 1 |
| Niedzielska, E | 1 |
| Jakubowski, M | 1 |
| Porwolik, J | 1 |
| Turek-Jakubowska, A | 1 |
| Szahidewicz-Krupska, E | 1 |
| Mazur, G | 1 |
| Chybicka, A | 1 |
| Szuba, A | 1 |
| Sulicka, J | 1 |
| Surdacki, A | 1 |
| Strach, M | 1 |
| Kwater, A | 1 |
| Gryglewska, B | 1 |
| Ćwiklińska, M | 1 |
| Balwierz, W | 1 |
| Grodzicki, TK | 1 |
3 other studies available for n(g),n(g')-dimethyl-l-arginine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications.
Topics: Adolescent; Arginine; Biomarkers; C-Reactive Protein; Child; E-Selectin; Endothelium, Vascular; Fema | 2018 |
Elevated plasma ADMA contributes to development of endothelial dysfunction in children with acute lymphoblastic leukemia.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Endothelial Cells; Endotheli | 2016 |
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Female; Humans; Male; Precursor Cell Lymphobla | 2012 |